date:May 11, 2012
not going to give on the synthetics issue.
Speaking to us after the guidance was first published, Wes Siegner, a director at Washington DC-based legal firm Hyman, Phelps McNamara, said the FDA's stance on syntheticbotanical constituents waslacking in scientific and legal merit.
The American Herbal Products Association (AHPA) has also come out strongly on this issue, adding:If DMAA exists in geranium through the plant's own synthesis processes, human-synthesized DMAA is also a lawful dietary i